ZY
Zhengye Biotechnology Holding Limited
ZYBT · NASDAQ
$1.33 -0.56% (-$0.01)
1M -29.74%
Market Cap ¥422.0M
P/E Ratio -
Div. Yield -
ROE 25.78%
Valuation
32 /100
Expensive P/S 3.63x
P/B 1.69x
P/FCF 600.25x
Growth
0 /100
Declining Rev. growth 23.53%
Book val. growth 5.55%
EPS growth N/A
Profitability
9 /100
Weak Gross margin 20.51%
Net margin 59.97%
FCF margin 0.60%
Quality
3 /100
Poor ROIC 20.63%
ROE 25.78%
Asset turnover 0.27x
Debt
57 /100
Moderate Debt/Equity 0.30x
Current ratio 1.14x
Int. coverage -20.14x
Stability
55 /100
Moderate Beta -2.53x
Rev. volatility 13.28%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ZYBT
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Songlin Song
Employees
269
Headquarters
Jilin